Search

Wei Wx Xu

from North Wales, PA
Age ~55
Get Report
Also known as:
Wei W Xu, We I Xu, Wei Luo
Phone and address:
104 Dickens Ct, North Wales, PA 19454
(215) 540-5221
Related to:
Xu LuoSihua Xu, 74Jialiang Xu, 83Yu Y Luo, 61
Connected to:
Alexander A Xu, 34Anqi Xu, 35Benjamin B Xu, 67Bonnie Xu, 37Bonny J Xu, 33Boris Xu, 33Changhai Xu, 54Charline Q Xu, 64Chengyuan Xu, 46Chris X Xu, 61

Wei Xu Phones & Addresses

  • 104 Dickens Ct, North Wales, PA 19454 (215) 540-5221
  • 104 Dickens Ct #65, North Wales, PA 19454 (215) 540-5221
  • 1141 Snyder Rd #B28, Lansdale, PA 19446 (215) 412-2918
  • West Lafayette, IN
  • W Lafayette, IN
  • Morehead, KY

Education

School / High School: Southern Methodist University, Dedman School of Law

Ranks

Licence: Texas - Eligible To Practice In Texas Date: 2011

Professional Records

Medicine Doctors

Wei Xu Photo 1

Wei A. Xu

View page
Specialties:
Family Medicine
Work:
Gaithersburg Family Medicine
604 S Frederick Ave STE 200, Gaithersburg, MD 20877
(240) 404-6423 (phone), (240) 404-6426 (fax)
Education:
Medical School
The Second Military Med Univ, Shanghai City, Shanghai, China
Graduated: 1989
Procedures:
Electrocardiogram (EKG or ECG)
Pulmonary Function Tests
Vaccine Administration
Conditions:
Abnormal Vaginal Bleeding
Acne
Acute Bronchitis
Allergic Rhinitis
Anemia
Languages:
Chinese
English
Description:
Dr. Xu graduated from the The Second Military Med Univ, Shanghai City, Shanghai, China in 1989. She works in Gaithersburg, MD and specializes in Family Medicine.
Wei Xu Photo 2

Wei Min Xu

View page
Specialties:
Family Medicine
Work:
Kaiser Permanente Medical GroupKaiser Permanente Sacramento Medical Center
2345 Fair Oaks Blvd, Sacramento, CA 95825
(916) 973-5000 (phone), (916) 480-6424 (fax)
Education:
Medical School
Guangzhou Med Coll, Guangzhou City, Guangdong, China
Graduated: 1982
Procedures:
Electrocardiogram (EKG or ECG)
Hearing Evaluation
Vaccine Administration
Conditions:
Acute Pharyngitis
Acute Sinusitis
Acute Upper Respiratory Tract Infections
Bronchial Asthma
Contact Dermatitis
Languages:
English
Description:
Dr. Xu graduated from the Guangzhou Med Coll, Guangzhou City, Guangdong, China in 1982. He works in Sacramento, CA and specializes in Family Medicine.
Wei Xu Photo 3

Wei Xu

View page
Specialties:
Physical Medicine & Rehabilitation
Work:
Bacharach Rehab MedicineBacharach Institute For Rehabilitation
61 W Jimmie Leeds Rd, Pomona, NJ 08240
(609) 748-5380 (phone), (609) 652-8749 (fax)
Education:
Medical School
The Second Military Med Univ, Shanghai City, Shanghai, China
Graduated: 1985
Languages:
English
Spanish
Description:
Dr. Xu graduated from the The Second Military Med Univ, Shanghai City, Shanghai, China in 1985. He works in Pomona, NJ and specializes in Physical Medicine & Rehabilitation. Dr. Xu is affiliated with Atlanticare Regional Medical Center and Shore Medical Center.
Wei Xu Photo 4

Wei Xu

View page
Specialties:
Physical Medicine & Rehabilitation
Work:
Hartford Orthopedic Medicine
100 Wl St STE 1B, Hartford, CT 06103
(860) 249-4466 (phone), (860) 249-4469 (fax)
Education:
Medical School
Capital Univ of Med Scis, Training Ctr of Gen Prac, Beijing City, China
Graduated: 1995
Languages:
English
Spanish
Description:
Dr. Xu graduated from the Capital Univ of Med Scis, Training Ctr of Gen Prac, Beijing City, China in 1995. He works in Hartford, CT and specializes in Physical Medicine & Rehabilitation.
Wei Xu Photo 5

Wei H. Xu

View page
Specialties:
Internal Medicine, Holistic Medicine
Work:
Doctors On-Call
6010 Bay Pkwy STE 901, Brooklyn, NY 11204
(718) 238-2100 (phone), (718) 748-0863 (fax)
Languages:
English
Description:
Ms. Xu works in Brooklyn, NY and specializes in Internal Medicine and Holistic Medicine. Ms. Xu is affiliated with Maimonides Medical Center, Mount Sinai Beth Israel Brooklyn Medical Center and New York Methodist Hospital.
Wei Xu Photo 6

Wei Ji Xu

View page
Specialties:
Anesthesiology
Education:
Jinzhou Medical College (1986)
Wei Xu Photo 7

Wei Xu

View page
Specialties:
Physical Medicine & Rehabilitation
Education:
Capital Medical College, Beijing (1995)

License Records

Wei Xu

License #:
MTL001430 - Active
Category:
MEDICINE
Issued Date:
Apr 22, 2013
Expiration Date:
Jul 31, 2017
Type:
MEDICAL TRAINING LICENSE I(B)

Lawyers & Attorneys

Wei Xu Photo 8

Wei Xu - Lawyer

View page
Licenses:
Texas - Eligible To Practice In Texas 2011
Education:
Southern Methodist University, Dedman School of Law
Languages:
Mandarin
Wei Xu Photo 9

Wei Xu - Lawyer

View page
ISLN:
1000218260
Admitted:
2016

Business Records

Name / Title
Company / Classification
Phones & Addresses
Wei Angela Xu
Ward & Xu, Pllc
Wei Xu
NEWARK 2005, LLC

Publications

Isbn (Books And Publications)

Machine Learning Techniques for Multimedia

View page
Author

Wei Xu

ISBN #

0387699384

Us Patents

Amine Salts Of An Integrin Receptor Antagonist

View page
US Patent:
6444680, Sep 3, 2002
Filed:
Nov 29, 2001
Appl. No.:
09/998416
Inventors:
Guy R. Humphrey - Hillsborough NJ
Marjorie See Waters - Cranbury NJ
Wei Xu - North Wales PA
Assignee:
Merck Co., Inc. - Rahway NJ
International Classification:
C07D40114
US Classification:
514256, 544333
Abstract:
Amine salts of -( -methyl-pyrimidin- -yl)- -( -tetrahydro-[ ]-naphthyridin- -yl)-nonanoic acid are potent antagonists of the integrin v receptor and are useful for the prevention and/or treatment of osteoporosis and vascular restenosis, as well as conditions associated with excessive angiogenesis, such as macular degeneration, diabetic retinopathy, atherosclerosis, inflammatory arthritis, cancer, and metastatic tumor growth. The invention also relates to a process for the preparation of the novel salts as well as pharmaceutical compositions containing the salts and methods of using the salts. Also disclosed are (R)- and (S)-( -methylpyrimidin- -yl)- -( -tetrahydro-[ ]naphthyridin- -yl)-nonanoic acid in the form of a zwitterion trihydrate.

Crystalline Forms Of An Integrin Receptor Antagonist

View page
US Patent:
6509347, Jan 21, 2003
Filed:
Jun 11, 2002
Appl. No.:
10/167678
Inventors:
Wei Xu - North Wales PA
Yaling Wang - Westfield NJ
Assignee:
Merck Co., Inc. - Rahway NJ
International Classification:
A61K 314375
US Classification:
514300, 546122
Abstract:
The present invention relates to novel crystalline forms of the integrin v3 antagonist 3-{2-oxo-3-[3-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)-propyl]imidazolidin-1-yl}-3(S)-(6-methoxy-pyridin-3-yl)-propionic acid.

Amine Salt Of An Integrin Receptor Antagonist

View page
US Patent:
6750220, Jun 15, 2004
Filed:
Jun 18, 2002
Appl. No.:
10/174016
Inventors:
Guy R. Humphrey - Hillsborough NJ
Wei Xu - North Wales PA
Assignee:
Merck Co., Inc. - Rahway NJ
International Classification:
C07D40114
US Classification:
514256, 544333
Abstract:
The tris(hydroxymethyl)aminomethane (âTRISâ) salt of 3-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-[1,8]-naphthyridin-2-yl)-nonanoic acid is a potent antagonist of the integrin v3 receptor and is useful for the prevention and/or treatment of osteoporosis and vascular restenosis, as well as conditions associated with excessive angiogenesis, such as macular degeneration, diabetic retinopathy, atherosclerosis, inflammatory arthritis, cancer, and metastatic tumor growth. The invention also relates to a process for the preparation of the novel salt as well as pharmaceutical compositions containing the salt and methods of using the salt.

Sodium Salt Of An Hiv Integrase Inhibitor

View page
US Patent:
6924282, Aug 2, 2005
Filed:
Aug 14, 2002
Appl. No.:
10/218537
Inventors:
Neville J. Anthony - Hatfield PA, US
Wei Xu - North Wales PA, US
John V. Lepore - Marlboro NJ, US
Amar J. Mahajan - Piscataway NJ, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D417/14
A61K031/541
A61P031/18
US Classification:
5142222, 544 3
Abstract:
A sodium salt of Compound A is disclosed, wherein Compound A is of formula: Compound A is an HIV integrase inhibitor useful for preventing or treating HIV infection, for delaying the onset of AIDS, and for treating AIDS.

Non-Destructive, High Order Harmonic Ion Motion Image Current Detection

View page
US Patent:
8362418, Jan 29, 2013
Filed:
May 29, 2009
Appl. No.:
12/990688
Inventors:
Wei Xu - West Lafayette IN, US
William Chappell - Lafayette IN, US
Zheng Ouyang - West Lafayette IN, US
Robert Graham Cooks - West Lafayette IN, US
Assignee:
Purdue Research Foundation - West Lafayette IN
International Classification:
B01D 59/44
US Classification:
250283, 250281, 250282
Abstract:
The invention herein generally relates to non-destructive, high order harmonic ion motion image current detection. In certain embodiments, ion motion corresponding to high order harmonic frequencies, instead of the secular frequencies, is detected using image current detection with a constant excitation applied to the waveform signal.

Phosphoric Acid Salt Of An Integrin Receptor Antagonist

View page
US Patent:
20050101593, May 12, 2005
Filed:
Oct 1, 2001
Appl. No.:
10/398366
Inventors:
Robert Meissner - Schwenksville PA, US
Wei Xu - North Wales PA, US
International Classification:
A61K031/55
C07D487/02
US Classification:
514215000, 540577000
Abstract:
The phosphoric acid salt of 3-(2-methoxy-pyrimidin-5-yl)-5-oxo-9-(6,7,8,9-tetrahydro-5H-pyrido[2,3-b]azepin-2-yl)-nonanoic acid is a potent antagonist of the integrin αvβ3 receptor and is useful for the prevention and/or treatment of osteoporosis and vascular restenosis, as well as conditions associated with excessive angiogenesis, such as macular degeneration, diabetic retinopathy, atherosclerosis, inflammatory arthritis, cancer, and metastatic tumor growth. The invention also relates to a process for the preparation of the novel salt as well as pharmaceutical compositions and methods of use.

Mannitol Formulation For Integrin Receptor Antagonist

View page
US Patent:
20060030581, Feb 9, 2006
Filed:
Sep 16, 2003
Appl. No.:
10/527605
Inventors:
Laura DeBusi - Schwenksville PA, US
Sami Karaborni - Lansdale PA, US
Bozen Matuszewska - North Wales PA, US
Adama Procopio - Cinnaminson PA, US
Wei Xu - North Wales PA, US
Chia-Yi Yang - North Wales PA, US
International Classification:
A61K 31/4745
US Classification:
514300000
Abstract:
Disclosed are pharmaceutical compositions of an integrin αvβ3 receptor antagonist containing mannitol as the binding agent. The compositions are prepared by wet granulation or direct compression tablet formulation. These pharmaceutical formulations are useful for inhibiting bone resorption associated with osteoporosis, metastatic bone disease, hypercalcemia of malignancy, and Paget's disease.

Pharmaceutical Composition Containing An Anti-Nucleating Agent

View page
US Patent:
20080118559, May 22, 2008
Filed:
Dec 2, 2005
Appl. No.:
11/792190
Inventors:
Maria T. Cruanes - Lansdale PA, US
Wei Xu - North Wales PA, US
Laura M. Artino - Cakhurst NJ, US
Honggang Zhu - Collegeville PA, US
International Classification:
A61K 31/519
A61K 31/513
A61K 9/20
US Classification:
424464, 5142595, 514269
Abstract:
Pharmaceutical compositions suitable for oral administration in solid dosage forms are described. The compositions comprise an effective amount of a drug compound in the form of a salt, wherein the drug salt is characterized by conversion to a less soluble form of the drug compound under certain pH conditions, and an anti-nucleating agent.
Control profile
Wei Wx Xu from North Wales, PA, age ~55 Get Report